FLARE OR INTER-FLARE, THE SOURCE OF INFLAMMATION IS THE SAME1,2
Different diseases.
Different drivers.
GPP has a distinct pathogenic mechanism from plaque psoriasis.3,4 Unlike in plaque psoriasis, dysregulated IL-36 signaling is a primary driver of GPP inflammation.5
Approximately half of patients with GPP have plaque psoriasis6
GPP4,7

- Innate immune inflammation
- Autoinflammatory (predominantly neutrophilic)
- Primarily driven by the IL-36 pathway
Reproduced with permission from Burden AD et al. The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity. Br J Dermatol. 2023;189(1):138-140.
Plaque psoriasis4,5

- Adaptive immune response
- Autoimmune disease (T cell–mediated)
- Primarily driven by the IL-17/IL-23 pathway
Reproduced with permission from ©DermNet, dermnetnz.org 2026.
IL-17, interleukin-17; IL-23, interleukin-23; IL-36, interleukin-36.